BCL2 and non-small cell lung carcinoma: In addition, XIST could regulate the SOD2 signalling pathway by targeting miR-335 to modulate NSCLC cell apoptosis, and XIST downregulation enhanced the expression of caspase-3 and Bax and decreased the expression of Bcl-2 by reducing SOD2 levels [54].